XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.24.3

Net Loss per Share | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Net Loss per Share | Net Loss per Share Basic loss per share is computed by dividing net loss attributable to vTv Therapeutics Inc. by the weighted average number of shares of Class A common stock outstanding during the period. Diluted loss per share is computed giving effect to all potentially dilutive shares. Diluted loss per share for all periods presented is the same as basic loss per share as the inclusion of potentially issuable shares would be antidilutive. A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A common stock is as follows (amounts in thousands, except per share amounts):
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
| 2024 |  | 2023(*) |  | 2024 |  | 2023(*)
Numerator: |  |  |  |  |  |  |
Net loss | $ | (5,840) |  |  | $ | (8,540) |  |  | $ | (18,268) |  |  | $ | (21,525) |
Less: Net loss attributable to noncontrolling interests | (1,057) |  |  | (1,886) |  |  | (3,440) |  |  | (4,753) |
Net loss attributable to common shareholders of vTv Therapeutics Inc., basic and diluted | (4,783) |  |  | (6,654) |  |  | (14,828) |  |  | (16,772) |
Denominator: |  |  |  |  |  |  |
Weighted average vTv Therapeutics Inc. Class A common stock, basic and diluted (1) | 5,456,307 |  |  | 2,084,973 |  |  | 5,498,479 |  |  | 2,084,973 |
Net loss per share of vTv Therapeutics Inc. Class A common stock, basic and diluted | $ | (0.88) |  |  | $ | (3.19) |  |  | $ | (2.70) |  |  | $ | (8.04) |
(*) Adjusted retroactively for reverse stock split |  |  |  |  |  |  |
| (1) | The shares underlying the pre-funded warrants to purchase shares of the Company’s common stock have been included in the calculation of the weighted-average number of shares outstanding, basic and diluted, for the three and nine months ended September 30, 2024.
Potentially dilutive securities not included in the calculation of dilutive net loss per share are as follows:
| September 30, 2024 |  | September 30, 2023
Class B common stock (1)(*) | 577,349 |  |  | 577,349 |
Common stock options granted under the Plan (*) | 691,593 |  |  | 238,636 |
Common stock warrants (*) | 75,595 |  |  | 80,359 |
Total (*) | 1,344,537 |  |  | 896,344 |
(*) Adjusted retroactively for reverse stock split |  |  |
___________________________
| (1) | Shares of Class B common stock do not share in the Company’s earnings and are not participating securities. Accordingly, separate presentation of loss per share of Class B common stock under the two-class method has not been provided. Each share of Class B common stock (together with a corresponding vTv Unit) is exchangeable for one share of Class A common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration